Syensqo Chemicals Unit Sale Draws PE Bids

A significant divestiture is on the horizon for Syensqo, as the Belgian specialty chemicals group is reportedly exploring the sale of its performance and care division. This strategic move, potentially valued at approximately €3 billion, has attracted the attention of several prominent private equity firms, including Blackstone and Apollo. Sources indicate that these investment powerhouses are among a select group evaluating bids for the substantial business unit.

The performance and care division, a key contributor to Syensqo's portfolio, serves diverse end markets such as consumer goods, agriculture, coatings, and mining. In the fiscal year 2025, this segment generated earnings before interest, taxes, depreciation, and amortization (EBITDA) of €358 million, underscoring its financial significance. The company's decision to consider divesting this unit stems from a broader strategic review initiated in May, spearheaded by CEO Mike Radossich. The objective is to sharpen Syensqo's focus on high-growth sectors like aerospace, defense, and energy, areas poised for robust long-term expansion.

The potential proceeds from this sale are earmarked for strategic deployment, which could include funding future acquisitions, deleveraging the balance sheet, or returning capital to shareholders. This proposed transaction follows Syensqo's recent successful divestiture of its oil and gas business to SNF Group in January. Furthermore, the company has indicated active discussions are underway for the sale of its aroma performance division, a business recognized as the world's leading integrated producer of vanillin.

Beyond Blackstone and Apollo, the competitive interest in Syensqo's chemicals arm extends to other major private equity players. Firms such as Cinven, Advent, and Bain Capital are also reportedly assessing offers for the division. This high level of interest from multiple sophisticated financial sponsors highlights the perceived value and strategic importance of the performance and care segment within the broader specialty chemicals industry.

The specialty chemicals market, particularly segments focused on performance materials and consumer-facing applications, has seen consistent demand driven by innovation and evolving consumer preferences. Companies offering tailored solutions for sectors like personal care and advanced coatings often command premium valuations. The €3 billion valuation being discussed for Syensqo's unit aligns with recent multiples seen in comparable divestitures of non-core chemical assets by larger conglomerates seeking to streamline operations and enhance shareholder value.

News of the potential sale spurred a positive market reaction, with Syensqo's shares experiencing an uptick of up to 3.7% in early trading. This suggests investor confidence in the strategic direction and the potential financial benefits derived from such a significant portfolio adjustment. The successful completion of this divestiture would mark another pivotal step in Syensqo's transformation into a more focused and agile entity.